MONONUCLEAR PHAGOCYTE-DERIVED GROWTH FACTOR
MONONUCLEAR PHAGOCYTE-DERIVED GROWTH FACTOR
批准号:
3169259
负责人:
G. YANCEY GILLESPIE
金额:
$11.97万
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-08-01 至 1988-03-31
关键词:
affinity chromatography cell differentiation cell growth regulation cell population study cell sorting fibroblasts gel electrophoresis gene expression growth factor high performance liquid chromatography hybridomas inflammation macrophage macrophage activating factor membrane activity molecular cloning monoclonal antibody monocyte monokines neoplastic transformation phagocytes radioimmunoassay radiotracer tissue /cell culture wound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this research is to develop our fundamental knowledge of the
basic mechanism(s) by which mononuclear phagocytes regulate proliferation
of various normal cell types. Our findings to date suggest that
macrophages and macrophage-like cell lines elaborate specific soluble
factor(s) that can cause quiescent fibroblasts to initiate traverse of the
cell cycle. Operationally, this monokine(s) is a "competence" factor,
similar in its action to other known competence factors (platelet-derived
growth factor and fibroblast growth factor) but biochemically distinct from
both. We have concentrated our efforts on purification of the
macrophage-derived competence factor (MDCF) from spent supernates of
cultured P388D1, a mouse macrophage-like cell line that elaborates generous
amounts of MDCF in addition to another growth factor, interleukin-1 (IL-1).
We have greatly simplified purification by adapting P388D1 cells to grow
continuously serum-free in a defined medium. Serial application of
ultrafiltration, gel filtration, and ion exchange chromatography has
clearly separated MDCF and IL-1, both in terms of biochemical/biophysical
properties and biological activities. Analysis by silver-stained SDS-PAGE
slab gels reveals two major bands of protein that correspond to MDCF
activity and one that corresponds to IL-1 activity. Companion studies of
affinity-purified IL-1 confirm our findings that MDCF and IL-1 are distinct
biochemical and biological entities. Using this greatly purified MDCF, we
are now beginning to develop specific antisera using rabbits and monoclonal
antibodies using rat-mouse hybridomas to identify and quantify MDCF for in
vivo and in vitro experiments. Our aim is to compare this monokine with
other known growth factors as an initial step in using these as probes to
dissect the cellular events associated with proliferation. The results
obtained should provide a foundation for definitive studies on the relation
of macrophage-derived competence factor production in vivo to lesions
characterized by mononuclear phagocyte accumulation, extensive fibroplasia,
and collagen deposition. (J)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glioblastoma tumor microenvironmental influence on acquired and inherent cancer therapy resistance.
-
批准号:10046398
-
项目类别:
-
资助金额:$29.77万
-
财政年份:2018
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
A Phase 1 Study of M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.
-
批准号:9455636
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2017
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Experimental Glioma Animal Models Core
-
批准号:8299607
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
-
批准号:8540977
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
-
批准号:8337752
-
项目类别:
-
资助金额:$70.0万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS
-
批准号:8147551
-
项目类别:
-
资助金额:$90.0万
-
财政年份:2011
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7908624
-
项目类别:
-
资助金额:$24.64万
-
财政年份:2009
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Experimental Glioma Animal Models Core
-
批准号:7747240
-
项目类别:
-
资助金额:$18.02万
-
财政年份:2009
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7454560
-
项目类别:
-
资助金额:$107.3万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7253509
-
项目类别:
-
资助金额:$12.48万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:6772544
-
项目类别:
-
资助金额:$233.77万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7848492
-
项目类别:
-
资助金额:$23.31万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7117060
-
项目类别:
-
资助金额:$10.36万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:6919955
-
项目类别:
-
资助金额:$234.39万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7463018
-
项目类别:
-
资助金额:$12.93万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
Molecular Therapeutics for Anaplastic Gliomas
-
批准号:7077704
-
项目类别:
-
资助金额:$233.14万
-
财政年份:2002
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6502919
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2001
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6324642
-
项目类别:
-
资助金额:$21.52万
-
财政年份:2000
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6103256
-
项目类别:
-
资助金额:$21.52万
-
财政年份:1999
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
CORE--EXPERIMENTAL GLIOMA TISSUE FACILITY
-
批准号:6269783
-
项目类别:
-
资助金额:$19.95万
-
财政年份:1998
-
负责人:G. YANCEY GILLESPIE
-
依托单位:
海外基金